Analystreport

Concert Pharmaceuticals Inc (NASDAQ: CNCE) was given a new $23.00 price target on by analysts at Mizuho. They now have a "buy" rating on the stock.

Concert Pharmaceuticals, Inc.  (CNCE) 
Last concert pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.concertpharma.com/investor-relations